On the positive side, continued growth in sales of key drugs like Darzalex, along with newer products such as Erleada and ...

We recently published a list of the 11 Cheap NYSE Stocks to Invest in According to Hedge Funds. In this article, we are going ...

Johnson & Johnson (JNJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

However, despite a 5% stock increase in the last quarter, JNJ's performance remained largely aligned with market movements, which experienced a volatile phase due to broad economic uncertainties ...

Johnson & Johnson (JNJ) is expected to deliver a year ... estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top ...

JOHNSON & JOHNSON (JNJ) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 87% based on the firm’s underlying fundamentals and the stock’s ...

However, InvestingPro analysis indicates that JNJ operates with moderate debt levels and maintains sufficient cash flows to cover interest payments. The stock generally trades with low price ...

This historical trend, if repeated, could indicate a favorable outlook for Johnson & Johnson’s stock performance moving forward. The upgrade reflects a positive sentiment on the part of Goldman ...